Parliament has voted in favour of amendment NC17 to the Trade Bill that will make it a negotiating objective for the UK Government to seek the UK's participation in the European medicines regulatory network.
The BIA has to responded to the announcement from government of the inaugural UKRI Future Leaders Fellowship Scheme will receive £900 million over the next 11 years.
BIA CEO Steve Bates said: “Today’s announcement will help to boost innovation in the UK and I am delighted to see that businesses will be able to use this scheme. It is vital that the UK government continues to support young entrepreneurs and business leaders to secure the innovation pipeline in the UK for the future.”
The BIA welcomes the creation of British Patient Capital, a £2.5 billion fund launched today by the British Business Bank. The fund will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors.
Today the Industrial Biotechnology Leadership Forum (IBLF) launches the new ‘National Industrial Biotechnology Strategy to 2030’, promoted in partnership with the UK BioIndustry Association (BIA). The Strategy has been developed by the IBLF and two collaborative networks in industrial biotech, CBMNet and BIOCATNET.
The BioIndustry Association (BIA) has called on the government to introduce a new venture capital fund structure that will give the public the opportunity to be partners in the UK’s biotech revolution. The fund should be based on the successful Enterprise Innovation Scheme (EIS) and include a new “Holding Relief”, which will reward individuals with further income tax relief if they stay invested in the long-term.
The BioIndustry Association and the Royal College of Physicians of London (RCP) have announced a collaborative partnership, offering both memberships increased opportunities to engage on issues such as innovation, access to the NHS and regulation.